{"entity":{"type":"insider","cik":"0001438421","url":"/insider/0001438421","json_url":"/insider/0001438421.json","name":"Webster Stephen W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":13,"first":"2011-06-27","last":"2022-08-04","span_basis":"filed_date"},"name_variants":[{"name":"Webster Stephen W","source":"filing","n_filings":13,"first_seen":"2011-06-27","last_seen":"2022-08-04"}],"transactions":[{"id":6770787,"accession":"0001104659-22-086279","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-086279","line_url":"/filing/0001104659-22-086279#line-1","is_derivative":false,"issuer_cik":"0001438421","issuer_name":"Nabriva Therapeutics plc","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001438421","owner_cik":"0001438421","owner_name":"Webster Stephen W","owner_display_name":"Webster Stephen W","owner_url":"/insider/0001438421","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7826.0,"shares_display":"7,826","price_per_share":0.19,"price_display":"0.19","price_state":"stated","total_value":1486.94,"total_display":"1,486.94","total_whole":"1,487","shares_owned_after":11447.0,"shares_owned_after_display":"11,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-04","scope":"insider"},{"id":5441036,"accession":"0001104659-21-100291","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-100291","line_url":"/filing/0001104659-21-100291#line-1","is_derivative":false,"issuer_cik":"0001438421","issuer_name":"Nabriva Therapeutics plc","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001438421","owner_cik":"0001438421","owner_name":"Webster Stephen W","owner_display_name":"Webster Stephen W","owner_url":"/insider/0001438421","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":777.0,"shares_display":"777","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":932.4,"total_display":"932.40","total_whole":"932","shares_owned_after":19273.0,"shares_owned_after_display":"19,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-04","scope":"insider"},{"id":5999842,"accession":"0001209191-18-034485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-034485","line_url":"/filing/0001209191-18-034485#line-1","is_derivative":false,"issuer_cik":"0001438421","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001438421","owner_cik":"0001438421","owner_name":"Webster Stephen W","owner_display_name":"Webster Stephen W","owner_url":"/insider/0001438421","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":5.214,"price_display":"5.21","price_state":"stated","total_value":41712.0,"total_display":"41,712.00","total_whole":"41,712","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-29","filed_date":"2018-05-31","scope":"insider"},{"id":6069146,"accession":"0001104659-18-035538","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-035538","line_url":"/filing/0001104659-18-035538#line-1","is_derivative":false,"issuer_cik":"0001438421","issuer_name":"Nabriva Therapeutics plc","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001438421","owner_cik":"0001438421","owner_name":"Webster Stephen W","owner_display_name":"Webster Stephen W","owner_url":"/insider/0001438421","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":4.59,"price_display":"4.59","price_state":"stated","total_value":36720.0,"total_display":"36,720.00","total_whole":"36,720","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-23","filed_date":"2018-05-23","scope":"insider"},{"id":4682117,"accession":"0001609351-17-000120","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001609351-17-000120","line_url":"/filing/0001609351-17-000120#line-2","is_derivative":false,"issuer_cik":"0001438421","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001438421","owner_cik":"0001438421","owner_name":"Webster Stephen W","owner_display_name":"Webster Stephen W","owner_url":"/insider/0001438421","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":70.14,"price_display":"70.14","price_state":"stated","total_value":701400.0,"total_display":"701,400.00","total_whole":"701,400","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-16","filed_date":"2017-11-20","scope":"insider"},{"id":4791989,"accession":"0001609351-17-000094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001609351-17-000094","line_url":"/filing/0001609351-17-000094#line-2","is_derivative":false,"issuer_cik":"0001438421","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001438421","owner_cik":"0001438421","owner_name":"Webster Stephen W","owner_display_name":"Webster Stephen W","owner_url":"/insider/0001438421","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":79.38,"price_display":"79.38","price_state":"stated","total_value":793800.0,"total_display":"793,800.00","total_whole":"793,800","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-15","filed_date":"2017-08-15","scope":"insider"},{"id":4245023,"accession":"0001609351-17-000088","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001609351-17-000088","line_url":"/filing/0001609351-17-000088#line-2","is_derivative":false,"issuer_cik":"0001438421","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001438421","owner_cik":"0001438421","owner_name":"Webster Stephen W","owner_display_name":"Webster Stephen W","owner_url":"/insider/0001438421","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2337.0,"shares_display":"2,337","price_per_share":71.12,"price_display":"71.12","price_state":"stated","total_value":166207.44,"total_display":"166,207.44","total_whole":"166,207","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4873178,"accession":"0001609351-17-000060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001609351-17-000060","line_url":"/filing/0001609351-17-000060#line-2","is_derivative":false,"issuer_cik":"0001438421","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001438421","owner_cik":"0001438421","owner_name":"Webster Stephen W","owner_display_name":"Webster Stephen W","owner_url":"/insider/0001438421","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7663.0,"shares_display":"7,663","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":459780.0,"total_display":"459,780.00","total_whole":"459,780","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-19","filed_date":"2017-06-21","scope":"insider"},{"id":4245009,"accession":"0001609351-17-000028","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001609351-17-000028","line_url":"/filing/0001609351-17-000028#line-4","is_derivative":false,"issuer_cik":"0001438421","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001438421","owner_cik":"0001438421","owner_name":"Webster Stephen W","owner_display_name":"Webster Stephen W","owner_url":"/insider/0001438421","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8102.0,"shares_display":"8,102","price_per_share":55.22,"price_display":"55.22","price_state":"stated","total_value":447392.44,"total_display":"447,392.44","total_whole":"447,392","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-25","filed_date":"2017-04-26","scope":"insider"},{"id":4245002,"accession":"0001609351-17-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001609351-17-000028","line_url":"/filing/0001609351-17-000028#line-2","is_derivative":false,"issuer_cik":"0001438421","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001438421","owner_cik":"0001438421","owner_name":"Webster Stephen W","owner_display_name":"Webster Stephen W","owner_url":"/insider/0001438421","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1898.0,"shares_display":"1,898","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":104390.0,"total_display":"104,390.00","total_whole":"104,390","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-24","filed_date":"2017-04-26","scope":"insider"},{"id":3137917,"accession":"0001609351-16-000045","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001609351-16-000045","line_url":"/filing/0001609351-16-000045","is_derivative":false,"issuer_cik":"0001438421","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001438421","owner_cik":"0001438421","owner_name":"Webster Stephen W","owner_display_name":"Webster Stephen W","owner_url":"/insider/0001438421","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":50.391,"price_display":"50.39","price_state":"stated","total_value":1007820.0,"total_display":"1,007,820.00","total_whole":"1,007,820","shares_owned_after":11500.0,"shares_owned_after_display":"11,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-20","filed_date":"2016-05-24","scope":"insider","n_lines":2},{"id":8437282,"accession":"0000899243-15-006598","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-15-006598","line_url":"/filing/0000899243-15-006598#line-2","is_derivative":false,"issuer_cik":"0001438421","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001438421","owner_cik":"0001438421","owner_name":"Webster Stephen W","owner_display_name":"Webster Stephen W","owner_url":"/insider/0001438421","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":48.86,"price_display":"48.86","price_state":"stated","total_value":977200.0,"total_display":"977,200.00","total_whole":"977,200","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-07","filed_date":"2015-10-09","scope":"insider"},{"id":8238033,"accession":"0001209191-15-010379","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-010379","line_url":"/filing/0001209191-15-010379#line-1","is_derivative":false,"issuer_cik":"0001438421","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001438421","owner_cik":"0001438421","owner_name":"Webster Stephen W","owner_display_name":"Webster Stephen W","owner_url":"/insider/0001438421","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":23.0,"price_display":"23.00","price_state":"stated","total_value":57500.0,"total_display":"57,500.00","total_whole":"57,500","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2015-02-06","scope":"insider"},{"id":8990437,"accession":"0001438421-11-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001438421-11-000001","line_url":"/filing/0001438421-11-000001#line-1","is_derivative":false,"issuer_cik":"0001076167","issuer_name":"ADOLOR CORP","issuer_ticker":"ADLR","issuer_name_source":null,"issuer_url":"/issuer/0001076167","owner_cik":"0001438421","owner_name":"Webster Stephen W","owner_display_name":"Webster Stephen W","owner_url":"/insider/0001438421","role":"Officer (SVP, Finance & CFO)","role_mark":"O","role_mark_label":"Officer (SVP, Finance & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.88,"price_display":"1.88","price_state":"stated","total_value":18800.0,"total_display":"18,800.00","total_whole":"18,800","shares_owned_after":137500.0,"shares_owned_after_display":"137,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-27","filed_date":"2011-06-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001641640","name":"Nabriva Therapeutics plc","url":"/issuer/0001641640","role":"Director","n_filings":3,"first_seen":"2018-05-23","last_seen":"2022-08-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001607678","name":"Viking Therapeutics, Inc.","url":"/issuer/0001607678","role":"Director","n_filings":1,"first_seen":"2018-05-31","last_seen":"2018-05-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001609351","name":"Spark Therapeutics, Inc.","url":"/issuer/0001609351","role":"Officer (Chief Financial Officer)","n_filings":8,"first_seen":"2015-02-06","last_seen":"2017-11-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001076167","name":"ADOLOR CORP","url":"/issuer/0001076167","role":"Officer (SVP, Finance & CFO)","n_filings":1,"first_seen":"2011-06-27","last_seen":"2011-06-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001438421","retrieved_at":"2026-08-25T10:08:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}